• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER POST-INFARCT VSD OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER POST-INFARCT VSD OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number POST INFARCT MUSCULAR VSD OCCLUDER
Device Problems Difficult to Fold, Unfold or Collapse (1254); Migration or Expulsion of Device (1395); Device Damaged by Another Device (2915)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/10/2023
Event Type  Injury  
Event Description
It was reported that on (b)(6), 2023, a 24mm amplatzer post-infarct muscular vsd occluder was implanted using a 10f amplatzer trevisio intravascular delivery system.On (b)(6), 2023, the device embolized into the right ventricle.On and unknown date, the device was snared and moved into the left ventricle.It was noted that there was a large amount of resistance moving the device with the snare.Upon inspection of the device, it was noted that the device had deformed into a cobra shape.It is thought that the device was caught in the tricuspid cords, so when the occluder was deployed the right disk didn't form correctly or elongate.The patient is reported to be stable.No additional information was provided.
 
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Manufacturer Narrative
An event of cobra shaped device deformity was reported.A returned device assessment could not be performed as the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all defined manufacturing specifications.Based on the information received, the cause of the reported incident could not be conclusively determined.Please note, per the amplatzer post-infarct muscular vsd occluder instructions for use instructions for use, arten600196897 revision a "warnings: caution: embolized devices must be removed.Embolized devices should not be withdrawn through intracardiac structures unless they have been adequately collapsed within a sheath.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER POST-INFARCT VSD OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT MEDICAL REG# 2135147
5050 nathan ln n
plymouth MN 55442
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key16685488
MDR Text Key312732484
Report Number2135147-2023-01476
Device Sequence Number1
Product Code MLV
UDI-Device Identifier05415067028143
UDI-Public05415067028143
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040040
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/18/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/05/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberPOST INFARCT MUSCULAR VSD OCCLUDER
Device Catalogue Number9-VSDMPIHDE-024
Device Lot Number8200473
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/16/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/10/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age72 YR
-
-